{"name":"AVAX Technologies","slug":"avax-technologies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Autologous, DNP-Modified Melanoma Vaccine","genericName":"Autologous, DNP-Modified Melanoma Vaccine","slug":"autologous-dnp-modified-melanoma-vaccine","indication":"Other","status":"phase_1"},{"name":"Autologous, DNP-Modified Vaccine","genericName":"Autologous, DNP-Modified Vaccine","slug":"autologous-dnp-modified-vaccine","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Autologous, DNP-Modified Melanoma Vaccine","genericName":"Autologous, DNP-Modified Melanoma Vaccine","slug":"autologous-dnp-modified-melanoma-vaccine","phase":"phase_1","mechanism":"Uses autologous tumor cells modified with dinitrophenyl (DNP) to enhance immune recognition and response against melanoma cells.","indications":[],"catalyst":""},{"name":"Autologous, DNP-Modified Vaccine","genericName":"Autologous, DNP-Modified Vaccine","slug":"autologous-dnp-modified-vaccine","phase":"phase_1","mechanism":"Uses DNP-modified autologous tumor cells to enhance immune system recognition and response against cancer cells.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQM0x1Vmx1U0lYX2p1NXVvaGkxSnBWV0pxQ3N0X3JmUUVsWVN2SG1OTmxveTJCQU5QV3hKczRKVEFORHNhOVlPbkRDQml2c1dPcDVTT090YkhFUDg3NUd6cTlMTjRUbXcyc19BcVdTdG05cWhWOXV1cldIdVN2Y1FzNmF0MG9Wa2pQaXBTNzIwNjNwaDJvUWdyQzEzOE94YWRrX0YyQm1RQTdQNkpXaXVlbw?oc=5","date":"2026-03-19","type":"pipeline","source":"Stock Titan","summary":"Nasdaq warns AVAX One (AVX) over sub-$1.00 share price and delisting risk - Stock Titan","headline":"Nasdaq warns AVAX One (AVX) over sub-$1.00 share price and delisting risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPVGpBdFhwVlhwX3piazdBNjl1MERRTTdmZEpuOF80M0k0Nnd4OEZRZ3dTOTZ4aHlkUXJkUHA1Z0FYd211ejFCeGYtQmhRMmVadDRkZ1pnbF9xVHlEU1ZzOVByblZnQl90ZmJ2dE5VQk1yMEZvVUpvNDBRSU5hTjF4RHBpXzE1Zmh6T19HdXNGcGZrR0dZT2REVExXWXpyemNVT2Z1cTdvWW1Hck1xMG14OEhudmNqTmk0ZXhKYngxdHU5ekpRelpEVXNBMWhHQzRfOURScXdUN3ZSZVN5NWxXM2JBUnBoUTlCZHhXaGlrMDNPS1NWMkl0N1g0dHBFbkw5YlowMWNvNA?oc=5","date":"2026-03-12","type":"pipeline","source":"The Globe and Mail","summary":"Centri Announces Participating Companies for Second Annual Capital Conference at Nasdaq - The Globe and Mail","headline":"Centri Announces Participating Companies for Second Annual Capital Conference at Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPY1dfWEQwSm5Ta2JtUFJYV2RRX1liczViTU4yaGI0aDh2TkxrQVBpa3ZycmNWM3F5bjhnSDltXzc1WmVuQjlaa2drNElNZmNXTGdvSVctZldudkpSaFVJWHNueHlmTkhyY0REc2hBc2Vwc2hzRTMxVmxsM0dyM3B4eHlTQ3FGQzg0Z2lNbk03clRCRlpqZ04ydGUyRHR2VGNHZE5JZWdHdV92QXlndFJtbDlNb19FN294bVFmWEEwdDJOOXNWSGdLX3l5UzRaN2RMRmxZNUVBQlJmUkJp?oc=5","date":"2026-01-27","type":"regulatory","source":"Benzinga","summary":"Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNckN3V2o4bGdMbGt0YWlabVdZQlRuTFJRNlk4OGJKdTFUWUozeW5tT0RxQ3RVUHdVcTFsVmwwVzhIQ2l2R05xNTdqZXRvOG1qUmdxSS11SmtUb0JKdXR5RGhiaHEtSnpnLU5oSjl4bGdBaC04cUViVE9WVEZCVGFxTUd4WmFhRm5Gb2ZBNDFkMEFZZVE0YTEtY3VZZXV0THhvdFcycE43YnR1U3dJQWthVDFUeHdfRDhhelAteHdmZmNOTnFOZ2twenp4ME1UUC1OZ0Vz?oc=5","date":"2025-11-24","type":"pipeline","source":"prnewswire.com","summary":"AVAX One's Treasury Holdings Reach Over 13.8 Million AVAX as of November 23, 2025 - prnewswire.com","headline":"AVAX One's Treasury Holdings Reach Over 13.8 Million AVAX as of November 23, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5FeG5famhnQm5fNDdiT0hzSnZUZURwZEswYVpsY0lsdzJLLWw3dm5jajBteUd5bXFEd21YNFJTQlZTc1JNNHVOSDIzcjJXRVd0b0Z6RVQzR0ZFY2vSAWBBVV95cUxOTm5KdkNsc1FkNHV6bmt2ZjR2WVlRMmRjcVltWXkyZ3p1ZWZUV2pHZTV5Tm1mOVB6Y1BKRTU4TjdUYmthZUZxUlhBeURFYk5MNTBoajl4U1dhRldIcnVZYmQ?oc=5","date":"2018-02-20","type":"pipeline","source":"CNBC","summary":"Jeff Jonas - CNBC","headline":"Jeff Jonas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxPWmROenVVb2FfUnZXY0o0Ml85VHFabzJmdlRERjRULXFiR2xnLUZGOHA4VnV4ckRFSUxJc1FtYkNPVXc2Z2hJOGhzbWN4eVRMMkdrQUdwS3dVNTBaSzVLX0VVS1NfY001Wkl5UWhudHZFdlpfS2dFSExrRy12dmVLblhBWkZPWlBJeG5Manh4WE9vdzJaangxdkFRcU1SOGowOHUxaVBSdUk4RUs4YlFoQzF1eXZMWUp5LWJXQ1d4UFFweWk0T2R1YmVHZkxsb0dWZWhHdzQ0djJpQThYblljMWlBbXhEYnJVRGExSDVPRDFqSmpyUmpUMzNaS0dyZXBPa0FzYTlwdlREWHFnYWVaSzNvSGJ5VVN3Vmt2Q1VjMWI5cDkwU3c2RUVacGhDZ0xW?oc=5","date":"2016-01-26","type":"trial","source":"prnewswire.com","summary":"AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial In Patients With Relapsed Stage III Or IV Ovarian Cancer. - prnewswire.com","headline":"AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial In Patients With Relap","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}